| Log in
Photo Credit: Shah Junaid/VCCircle

Aurobindo Pharma ends big-ticket bid for Mallinckrodt’s generics biz

26 October, 2017

Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the generics business of UK-based Mallinckrodt Plc in what could have been the biggest overseas acquisition ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Temasek-backed Intas to buy Teva’s operations under Actavis in UK & Ireland for $769 mn

Temasek-backed Intas to buy Teva’s operations under Actavis in UK & Ireland for $769 mn

TEAM VCC 1 year ago
World’s largest generic drugmaker Teva Pharmaceutical Industries Ltd said on...
Cipla, Aurobindo Pharma to acquire drugs from Teva

Cipla, Aurobindo Pharma to acquire drugs from Teva

Ranjani R 1 year ago
Cipla Ltd and Aurobindo Pharma Ltd have agreed to acquire some generic drugs...
Aurobindo Pharma to buy Hyacinths Pharma, remaining stake in Silicon Life Sciences

Aurobindo Pharma to buy Hyacinths Pharma, remaining stake in Silicon Life Sciences

Lohit Jagwani 4 years ago
Aurobindo Pharma Ltd is acquiring Andhra Pradesh-based manufacturer of active...
No Comments

Aurobindo Pharma ends big-ticket bid for Mallinckrodt’s generics biz

Powered by WordPress.com VIP